Cargando…
Vericiguat in Heart Failure with a Reduced Ejection Fraction: Patient Selection and Special Considerations
With improvement in the understanding of the pathophysiological mechanisms of heart failure with reduced ejection fraction (HFrEF), several drug classes have been developed targeting the renin–angiotensin–aldosterone system, the beta adrenergic system, and to a certain extent the nitric oxide pathwa...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977472/ https://www.ncbi.nlm.nih.gov/pubmed/35386181 http://dx.doi.org/10.2147/TCRM.S357422 |